Bio-Techne Corp(TECH) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates in two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment offers proteins and reagent solutions, including cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and T-Cell activation technologies. This segment also provides manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including Food and Drug Administration -regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for original equipment manufacturers and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays comprising the ExoDx Prostate test for prostate cancer diagnosis. This segment also manufactures and sells tissue-based in-situ hybridization assays for research and clinical use. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Current Price

$416.80

RSI

29.002

Beta:

1.104247

February 08, 2021
0.51 %
$ 1.28
0 %
20.970 %
25M
132.9M

22.551 %
7.172 %
-62.416 %
120.129 %

$1,458,185,000
$1,406,307,000
$632,805,000
$563,003,000
$-1,748,000
$452,246,000
3.689 %
122.234 %
12.398 %
100.310 %
-25972.197 %

$276,477,000
$112,015,000
$125,952,000
$111,961,000
$147,481,000
$154,162,000
146.821 %
-12.442 %
12.496 %
-31.725 %
-4.530 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.